National Institutes of Health Federal Grants

Showing results 576-600 of 2,067 for National Institutes of Health federal grants, government grants and loans. For detailed information on a National Institutes of Health federal grant including eligibility requirements or financial assistance, click the title.

 

Molecular and Cellular Substrates of Complex Brain Disorders (R01)
This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal...
www.FederalGrantsWire.com/molecular-and-cellular-s...

NIMH Short Courses for Mental Health-Related Research Education (R25)
The over-arching goal of this NIMH R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To this end, this funding...
www.FederalGrantsWire.com/nimh-short-courses-for-m...

NIMH Research Education Programs for Psychiatry Residents (R25)
The goal of this NIMH R25 program is to support educational activities that help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences. To this end, this funding...
www.FederalGrantsWire.com/nimh-research-education-...

Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
The purpose of this initiative is to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease.
www.FederalGrantsWire.com/platform-delivery-techno...

Molecular and Cellular Substrates of Complex Brain Disorders (R21)
This Funding Opportunity Announcement (FOA) uses the R21 mechanism to encourage new research activities directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular...
www.FederalGrantsWire.com/molecular-and-cellular-s...

Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54)
NIH established the Institutional Development Award (IDeA) program in 1993 to enhance biomedical research activities in states that have had historically low NIH grant funding success rates. The purpose of this Funding Opportunity Announcement (FOA)...
www.FederalGrantsWire.com/institutional-developmen...

NIDDK Central Repositories Non-renewable Sample Access (X01)
The NIDDK Central Repositories house valuable samples and data from numerous major clinical studies. This FOA allows investigators to apply for access to non-renewable samples from one or more of these studies. Information about the samples...
www.FederalGrantsWire.com/niddk-central-repositori...

NINDS CREATE Devices: Translational and Early Feasibility Studies on the Path to Pre-Market Approval (PMA) or Humanitarian Device Exemption (HDE) (UH2/UH3)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and Early Feasibility Studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement...
www.FederalGrantsWire.com/ninds-create-devices-tra...

NINDS CREATE Devices: Translational and Clinical Studies to Inform Final Device Design (UH2/UH3)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and clinical studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism...
www.FederalGrantsWire.com/ninds-create-devices-tra...

NINDS CREATE Devices: Translational and Clinical Studies on the Path to 510(k) (UH2/UH3)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and clinical studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism...
www.FederalGrantsWire.com/ninds-create-devices-tra...

Bioreactors for Reparative Medicine (R41/R42)
Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop sophisticated and complex...
www.FederalGrantsWire.com/bioreactors-for-reparati...

Bioreactors for Reparative Medicine (R43/R44)
Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop sophisticated and complex...
www.FederalGrantsWire.com/bioreactors-for-reparati...

Arts-Based Approaches in Palliative Care for Symptom Management (R01)
The purpose of this funding opportunity announcement (FOA) is to support mechanistic clinical studies aimed at understanding the impact of arts-based approaches in palliative care for symptom management. This FOA is intended to support mechanistic...
www.FederalGrantsWire.com/arts-based-approaches-in...

Bioreactors for Reparative Medicine - SBIR Direct Phase II (R44)
Major obstacles to the generation of functional tissues and their widespread use are limited by rudimentary tissue growth technologies. The purpose of this funding opportunity is to encourage small businesses to develop sophisticated and complex...
www.FederalGrantsWire.com/bioreactors-for-reparati...

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UH2/UH3)
The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN receive funding for...
www.FederalGrantsWire.com/blueprint-neurotherapeut...

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)
The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN receive funding for...
www.FederalGrantsWire.com/blueprint-neurotherapeut...

NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)
This Funding Opportunity Announcement (FOA) is dedicated to the discovery of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS...
www.FederalGrantsWire.com/ninds-create-bio-discove...

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)
This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS...
www.FederalGrantsWire.com/ninds-create-bio-develop...

NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)
This Funding Opportunity Announcement (FOA) is dedicated to the discovery of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS...
www.FederalGrantsWire.com/ninds-create-bio-discove...

NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)
This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS...
www.FederalGrantsWire.com/ninds-create-bio-develop...

High Throughput Screening (HTS) to Discover Chemical Probes (R21)
This Funding Opportunity Announcement (FOA) encourages investigators to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement...
www.FederalGrantsWire.com/high-throughput-screenin...

High Throughput Screening (HTS) to Discover Chemical Probes (R01)
This Funding Opportunity Announcement (FOA) encourages investigators to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement...
www.FederalGrantsWire.com/high-throughput-screenin...

Innovative Research in Cancer Nanotechnology (IRCN) (U01)
This Funding Opportunity Announcement (FOA) invites applications for the development of innovative research projects in cancer nanotechnology. This initiative, to be known as Innovative Research in Cancer Nanotechnology (IRCN), is an integral...
www.FederalGrantsWire.com/innovative-research-in-c...

Career Transition Award for NINDS Intramural Clinician-Scientists (K22)
The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural...
www.FederalGrantsWire.com/career-transition-award-...

Connectomes Related to Human Disease (U01)
This Funding Opportunity Announcement (FOA) invites applications to build on the data collected using the very well defined experimental protocols of the Human Connectome Project (HCP) (http://www.neuroscienceblueprint.nih.gov/connectome/). ...
www.FederalGrantsWire.com/connectomes-related-to-h...